0001127602-16-061886.txt : 20160906 0001127602-16-061886.hdr.sgml : 20160906 20160906144010 ACCESSION NUMBER: 0001127602-16-061886 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160901 FILED AS OF DATE: 20160906 DATE AS OF CHANGE: 20160906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 161870620 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-09-01 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 Executive Chairman Common Stock 2016-08-05 5 J 0 E 731917 0 A 731917 I By Trust Common Stock 2016-08-05 5 G 0 E 731917 0 D 3287810 D Common Stock 2016-08-30 5 G 0 E 156714 0 D 3131096 D Common Stock 2016-09-01 4 M 0 100000 16.395 A 3231096 D Common Stock 2016-09-01 4 S 0 95600 77.451 D 3135496 D Common Stock 2016-09-01 4 S 0 4400 78.1926 D 3131096 D Non-qualified Stock Option (Right to Buy) 16.395 2016-09-01 4 M 0 100000 0 D 2017-01-22 Common Stock 100000 300000 D Shares gifted to family trust. Shares gifted to charitable trust Sale prices reported for the transactions reported here range from $77.06 to $78.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $78.07 to $78.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. /s/ Marissa Song by Power of Attorney for John C. Martin 2016-09-06